82 related articles for article (PubMed ID: 27568665)
1. P16INK4a: a potential diagnostic adjunct for prediction of high-grade cervical lesions in liquid-based cytology: with HPV testing and histological correlation.
Wong YP; Abdul Raub SH; Mohd Dali AZ; Kassim F; Visvalingam V; Zakaria Z; Kamaluddin MA; Noor Akmal S
Malays J Pathol; 2016 Aug; 38(2):93-101. PubMed ID: 27568665
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
[TBL] [Abstract][Full Text] [Related]
3. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
5. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
6. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
7. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
8. P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization.
Aumayr K; Susani M; Horvat R; Wrba F; Mazal P; Klatte T; Koller A; Neudert B; Haitel A
Int J Immunopathol Pharmacol; 2013; 26(3):611-20. PubMed ID: 24067458
[TBL] [Abstract][Full Text] [Related]
9. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.
Kocsis A; Takács T; Jeney C; Schaff Z; Koiss R; Járay B; Sobel G; Pap K; Székely I; Ferenci T; Lai HC; Nyíri M; Benczik M
Int J Cancer; 2017 Mar; 140(5):1119-1133. PubMed ID: 27874187
[TBL] [Abstract][Full Text] [Related]
10. The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions.
Huang MZ; Huang S; Li DQ; Nie XM; Li HB; Jiang XM
Med Oncol; 2011 Dec; 28 Suppl 1():S547-52. PubMed ID: 21053103
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
12. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
13. Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature.
Savone D; Carrone A; Riganelli L; Merlino L; Mancino P; Benedetti Panici P
Tumori; 2016 Oct; 102(5):450-458. PubMed ID: 27443891
[TBL] [Abstract][Full Text] [Related]
14. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
15. P16INK4A--A possible marker in HPV persistence screening.
Bleotu C; Botezatu A; Goia CD; Socolov D; Corniţescu F; Teleman S; Huică I; Iancu I; Anton G
Roum Arch Microbiol Immunol; 2009; 68(3):183-9. PubMed ID: 20361540
[TBL] [Abstract][Full Text] [Related]
16. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
17. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
[TBL] [Abstract][Full Text] [Related]
18. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions.
Calil LN; Igansi CN; Meurer L; Edelweiss MI; Bozzetti MC
Braz J Infect Dis; 2011; 15(2):126-31. PubMed ID: 21503398
[TBL] [Abstract][Full Text] [Related]
20. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
